CVE-2023-38958
Published: 03 August 2023
Summary
CVE-2023-38958 is a medium-severity Incorrect Authorization (CWE-863) vulnerability in Zkteco Bioaccess Ivs. Its CVSS base score is 5.3 (Medium).
Operationally, ranked at the 41.9th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2023-42718
Vulnerability details
An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Periodic review and update of procedures reduces incorrect authorization implementations over time.
Supervision identifies cases where authorization logic incorrectly permits unauthorized actions.
Defining permitted attribute values and auditing modifications reduces the chance of incorrect authorization outcomes due to tampered or missing labels.
The authorization process and usage restrictions help prevent incorrect authorization for remote access types.
Establishing configuration and connection requirements helps ensure correct rather than incorrect authorization for wireless access.
Establishing connection authorization processes for mobile devices helps ensure authorization decisions are correctly implemented rather than incorrect.
Monitoring account use, notifying on changes, and reviewing accounts for compliance corrects incorrect authorization assignments.
Ensures authorization decisions for external system use are correctly implemented and enforced.